Search - tctmd.com

Displaying 181 - 200 of 708

Sort: Relevancy | Date

Presentation TCT 2021

Equipoise Is a Myth: NOACs Will Be Superior to LAAO

Presenter: Renato D. Lopes

November 06, 2021

Presentation TCT 2021

ICE Imaging Is Not Ready for Prime-Time: TEE Should Be the Default Approach

Presenter: Brijeshwar Maini

November 06, 2021

Presentation TCT 2021

ICE Imaging Should Be the Default Approach to LAAC Procedural Imaging

Presenter: Mohamad A. Alkhouli

November 06, 2021

Presentation TCT 2021

Oral Anticoagulation Should Be the Default Strategy After LAAC

Presenter: Matthew J. Price

November 06, 2021

Presentation TCT 2021

Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC

Presenter: Jacqueline Saw

November 06, 2021

Presentation TCT 2021

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

Presenter: Roberto Galea

November 06, 2021

News Conference News TCT 2021

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

Todd Neale

November 06, 2021

Presentation TCT 2021

Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective

Presenter: Kan Fang

November 05, 2021

News Conference News TCT 2021

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

Todd Neale

November 05, 2021

Presentation TCT 2021

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

Presenter: Pavel Osmancik

November 05, 2021

Presentation TCT 2021

AMULET IDE: One-Year Device Closure From a Randomized Trial of Amulet Versus Watchman for Left Atrial Appendage Occlusion

Presenter: Dhanunjaya Lakkireddy

November 05, 2021

Presentation TCT 2021

TCT 567: Unusual Case of Severe Left Circumflex Coronary Artery Stenosis Following Left Atrial Appendage Closure

Presenter: Naeem Tahirkheli

November 04, 2021

Presentation TCT 2021

TCT 566: Residual Left Atrial Appendage Leak Following Percutaneous Left Atrial Appendage Occlusion: An Arising Problem of The Emerging Procedure

Presenter: Chanavuth Kanitsoraphan

November 04, 2021

Presentation TCT 2021

TCT 565: Left Atrial Intramural Hematoma

Presenter: Aditya Kesari

November 04, 2021

Presentation TCT 2021

TCT 564: A New Perspective: Intracardiac Echocardiographic Guidance for the Implantation of a Left Atrial Appendage Occluder Device (Watchman) with a Leadless Pacemaker (Micra)

Presenter: Kristen Brown

November 04, 2021

Presentation TCT 2021

TCT 563: Left Atrial Appendage Occlusion via Transhepatic Access in a Patient With Inferior Vena Cava Occlusion

Presenter: Ahmed El Shaer

November 04, 2021

Presentation TCT 2021

LAA Closure with the Laminar Device: technology and Clinical Update

Presenter: Jason H. Rogers

November 04, 2021

World’s First Dedicated 3D Sizing LAA Exclusion Device (Paladin Medical’s Trinity System)

Presentation TCT 2021

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Presenter: Flavio Airoldi

November 04, 2021

Presentation TCT 2021

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Presenter: Zachi Berger

November 04, 2021

Presentation TCT 2021

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

Presenter: Jens Erik Nielsen-Kudsk

November 04, 2021

Advertisement

Equipoise Is a Myth: NOACs Will Be Superior to LAAO

ICE Imaging Is Not Ready for Prime-Time: TEE Should Be the Default Approach

ICE Imaging Should Be the Default Approach to LAAC Procedural Imaging

Oral Anticoagulation Should Be the Default Strategy After LAAC

Antiplatelet Therapy Is Sufficient for DRT Prevention After LAAC

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

Amulet LAA Closure Device Has Fewer Leaks Than Watchman: Does It Matter?

Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

PRAGUE-17: Three-Year Outcomes From a Randomized Trial of Left Atrial Appendage Closure Versus Direct Acting Oral Anticoagulation in Patients With Atrial Fibrillation

AMULET IDE: One-Year Device Closure From a Randomized Trial of Amulet Versus Watchman for Left Atrial Appendage Occlusion

TCT 567: Unusual Case of Severe Left Circumflex Coronary Artery Stenosis Following Left Atrial Appendage Closure

TCT 566: Residual Left Atrial Appendage Leak Following Percutaneous Left Atrial Appendage Occlusion: An Arising Problem of The Emerging Procedure

TCT 565: Left Atrial Intramural Hematoma

TCT 564: A New Perspective: Intracardiac Echocardiographic Guidance for the Implantation of a Left Atrial Appendage Occluder Device (Watchman) with a Leadless Pacemaker (Micra)

TCT 563: Left Atrial Appendage Occlusion via Transhepatic Access in a Patient With Inferior Vena Cava Occlusion

LAA Closure with the Laminar Device: technology and Clinical Update

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content